RecruitingPhase IEN originalLymphoma

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

This study will evaluate the safety, efficacy, and pharmacokinetics of mosunetuzumab or glofitamab in combination with CELMoDs (CC-220 and/or CC-99282) in participants with B-cell NHL.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Wiek co najmniej 18 lat
  • Dobry ogólny stan zdrowia (zdolność do codziennych aktywności)
  • Chłoniak typu B-komórkowego, który powrócił lub nie odpowiadał na poprzednie leczenie
  • Guzy widoczne w badaniach obrazowych (tomografia, PET)
  • Próbka tkanki potwierdzająca rozpoznanie chłoniaka
  • Prawidłowe parametry krwi bez konieczności transfuzji w ostatnich 14 dniach
  • Normalne wyniki badań laboratoryjnych

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
July 13, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (26)

UCSF/Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program

San Francisco, United States

University of Colorado

Aurora, United States

Moffitt Cancer Center

Tampa, United States

The University of Chicago

Chicago, United States

Levine Cancer Institute

Charlotte, United States

UT MD Anderson Cancer Center

Houston, United States

Soroka

Beersheba, Israel

Rambam Health Care Campus

Haifa, Israel

Hadassah University Hospital - Ein Kerem

Jerusalem, Israel

Center Hospital

Ramat Gan, Israel

Sourasky Medical Center

Tel Aviv, Israel

IRCCS Azienda Ospedaliero Universitaria di Bologna

Bologna, Italy

IRCCS Istituto Romagnolo per lo studio dei tumori "Dino Amadori"

Meldola, Italy

ASST Spedali Civili di Brescia

Brescia, Italy

Irccs Ospedale San Raffaele

Milan, Italy

Azienda Ospedaliero Universitaria Pisana-Ospedale Santa Chia

Pisa, Italy

ICO L'Hospitalet

L'Hospitalet de Llobregat, Spain

Hospital Universitario La Fe

Valencia, Spain

Hospital Universitari Vall d Hebron

Barcelona, Spain

Clinica Universidad de Navarra-Madrid

Madrid, Spain

Hospital General Universitario Gregorio Maranon

Madrid, Spain

Hosp Universitario Salamanca

Salamanca, Spain

NHS Greater Glasgow and Clyde

Glasgow, United Kingdom

University College London Hospitals

London, United Kingdom

Nottingham University Hospitals City Campus

Nottingham, United Kingdom

Oxford University Hospitals NHS Trust - Churchill Hospital

Oxford, United Kingdom

Trial contact

Reference Study ID Number: CO43805 https://forpatients.roche.com/ No attachments to email below.

Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/14/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.